Encompass Health Corporation $EHC Shares Acquired by Inspire Investing LLC

Posted by Brenda Bartman on Jun 30th, 2026

Inspire Investing LLC boosted its position in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 22.5% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 49,812 shares of the company’s stock after buying an additional 9,165 shares during the period. Inspire Investing LLC’s holdings in Encompass Health were worth $4,818,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its position in Encompass Health by 24.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock worth $510,047,000 after acquiring an additional 948,202 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after purchasing an additional 3,793,358 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Encompass Health by 21.7% in the 4th quarter. Wellington Management Group LLP now owns 3,384,877 shares of the company’s stock worth $359,271,000 after purchasing an additional 603,472 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in shares of Encompass Health by 27.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,722,887 shares of the company’s stock worth $289,008,000 after purchasing an additional 581,812 shares in the last quarter. Finally, Alliancebernstein L.P. raised its holdings in shares of Encompass Health by 23.4% in the 3rd quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after purchasing an additional 476,564 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Trading Down 0.7%

NYSE EHC opened at $100.60 on Tuesday. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The stock has a market cap of $9.98 billion, a price-to-earnings ratio of 16.79, a PEG ratio of 2.21 and a beta of 0.72. The firm’s 50 day moving average price is $103.15 and its two-hundred day moving average price is $103.49.

Encompass Health (NYSE:EHC – Get Free Report) last released its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities analysts anticipate that Encompass Health Corporation will post 5.97 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health’s dividend payout ratio is currently 12.69%.

Analysts Set New Price Targets

A number of analysts recently weighed in on EHC shares. Leerink Partners set a $152.00 target price on shares of Encompass Health in a report on Friday, May 22nd. TD Cowen started coverage on Encompass Health in a report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price target on the stock. Weiss Ratings downgraded Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday. Barclays reduced their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Finally, Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $143.86.

Check Out Our Latest Report on Encompass Health

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the sale, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 1.80% of the company’s stock.

Encompass Health Profile

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.